In mice with cancer, giving them creatine at doses similar to what humans take causes more cancer spread (metastasis) and shorter survival times.
From A New Study Just Linked Creatine To Cancer · videoSee the scientific wording
Creatine supplementation at human-equivalent doses increases metastatic dissemination and reduces survival in mouse models of cancer.
There's disagreement
ObservationalThe 3 studies we reviewed point in different directions — there's no clear consensus.
What the research says
3 studies reviewedSupporting (2)
Cross-Sectional StudyHuman2026
The study gave mice creatine at doses similar to what people take and found that it made their cancer spread more and shortened their lives, just like the claim says.
Creatine promotes cancer metastasis through activation of Smad2/3.
Cohort StudyAnimal2021
The study gave mice creatine in amounts similar to what people take, and it caused their cancers to spread more and made them die faster.
Contradicting (1)
Creatine uptake promotes dendritic cell activation and enhances antitumor immunity
Cohort StudyHuman2026
The study shows that giving creatine to mice with cancer actually helps their immune system fight the cancer and makes tumors grow slower, which is the opposite of what the claim says.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Creatine taken as a supplement enters megakaryocytes, the cells that make platelets. Inside these cells, creatine increases the production of creatine kinase B, which modifies a protein called STAT5B. This modification turns on genes that make platelets hyperactive. Hyperactive platelets stick to cancer cells in the blood, helping them escape blood vessels and form new tumors in distant organs, leading to increased metastasis.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 2 supporting, 1 contradicting studies
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
In mice with cancer, giving them creatine at doses similar to what humans take causes more cancer spread (metastasis) and shorter survival times.
Mechanism
3 studiesCreatine supplementation increases metastasis through two biological pathways: it makes platelets hyperactive to assist cancer cell spread, and it directly alters cancer cell signaling to increase their mobility. However, some studies find that creatine also boosts immune cells that fight cancer, creating conflicting evidence.
Creatine taken as a supplement enters megakaryocytes, the cells that make platelets. Inside these cells, creatine increases the production of creatine kinase B, which modifies a protein called STAT5B. This modification turns on genes that make platelets hyperactive. Hyperactive platelets stick to cancer cells in the blood, helping them escape blood vessels and form new tumors in distant organs, leading to increased metastasis.
Creatine enters megakaryocytes via the creatine transporter SLC6A8, increasing intracellular creatine levels.
Elevated creatine upregulates the expression of creatine kinase B (CKB) in megakaryocytes.
CKB phosphorylates STAT5B at a non-canonical tyrosine residue.
Phosphorylated STAT5B activates transcription of genes that enhance platelet function.
Increased expression of platelet functional genes renders platelets hyperactive, with enhanced adhesion, aggregation, and release of pro-metastatic factors.
Hyperactive platelets interact with circulating tumor cells, promoting their survival, extravasation, and establishment of metastatic foci.
Less supported by current evidence, but not ruled out
Creatine directly affects cancer cells by activating a protein called MPS1. MPS1 then modifies Smad2 and Smad3 proteins, which turn on genes for Snail and Slug. These proteins make cancer cells more mobile and invasive, allowing them to break away from the primary tumor and spread to other organs.
Creatine (from diet or synthesized by GATM) activates MPS1 kinase.
MPS1 phosphorylates Smad2 and Smad3.
Phosphorylated Smad2/3 translocate to the nucleus and upregulate expression of Snail and Slug.
Snail and Slug repress E-cadherin and induce epithelial-mesenchymal transition, enhancing cell motility and invasiveness.
Increased motility and invasiveness promote metastatic dissemination.
Evidence from Studies
Last searched 2mo ago
Supporting (2)
Community contributions welcome
Exogenous creatine supplementation promotes tumor metastasis via megakaryocyte creatine kinase B-STAT5B signaling.
The study gave mice creatine at doses similar to what people take and found that it made their cancer spread more and shortened their lives, just like the claim says.
Creatine promotes cancer metastasis through activation of Smad2/3.
The study gave mice creatine in amounts similar to what people take, and it caused their cancers to spread more and made them die faster.
Contradicting (1)
Community contributions welcome
Creatine uptake promotes dendritic cell activation and enhances antitumor immunity
The study shows that giving creatine to mice with cancer actually helps their immune system fight the cancer and makes tumors grow slower, which is the opposite of what the claim says.
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review of Animal Studies on Creatine Supplementation and Cancer Metastasis
Comprehensive search of databases for all controlled animal studies comparing creatine supplementation (human-equivalent dosing) vs control in mouse cancer models, with outcomes including metastatic foci count, overall survival, and tumor burden. Meta-analysis if sufficient homogeneity.
Randomized Controlled Trial of Creatine vs Placebo in Mouse Model of Breast Cancer Metastasis
Double-blind, placebo-controlled randomized trial: 100 mice injected with metastatic cancer cells, randomized to receive creatine (human-equivalent dose) or placebo in drinking water for 8 weeks. Primary outcomes: number of metastatic nodules in lungs/liver, survival time. Secondary outcomes: primary tumor growth rate, body weight.
Prospective Cohort Study of Creatine Supplementation in Genetically Diverse Mouse Strains with Cancer
Prospective follow-up of multiple mouse strains with spontaneous or induced tumors, stratified by creatine intake (none, low, human-equivalent, high). Measure metastasis incidence and survival over life course, controlling for genetic background and other factors.
Controlled Laboratory Experiment on Creatine Effects on Metastatic Efficiency in Mouse Cancer Models
In vivo experiment: inject cancer cells into mice, administer creatine or control, then quantify metastatic colonies in target organs. Also, in vitro assays for cell migration and invasion with creatine treatment.